Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
573.81M | 545.53M | 463.41M | 381.05M | 218.34M | 141.41M | Gross Profit |
221.07M | 215.62M | 178.26M | 147.57M | 57.14M | 33.29M | EBIT |
-53.68M | -56.15M | -73.58M | -73.23M | -58.69M | -27.62M | EBITDA |
-29.02M | -28.20M | -52.30M | -59.53M | -55.88M | -25.83M | Net Income Common Stockholders |
-48.86M | -50.40M | -67.47M | -76.01M | -59.41M | -31.39M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
231.38M | 239.84M | 268.78M | 319.43M | 116.73M | 59.87M | Total Assets |
690.11M | 680.13M | 707.39M | 736.92M | 502.59M | 88.96M | Total Debt |
293.91M | 295.14M | 299.52M | 302.32M | 22.47M | 17.90M | Net Debt |
278.40M | 272.90M | 246.09M | -17.11M | -63.79M | -41.98M | Total Liabilities |
379.08M | 364.53M | 376.97M | 362.09M | 77.10M | 39.50M | Stockholders Equity |
309.90M | 314.45M | 329.30M | 373.74M | 424.45M | 49.46M |
Cash Flow | Free Cash Flow | ||||
-26.59M | -33.48M | -48.36M | -76.22M | -74.83M | -26.24M | Operating Cash Flow |
-7.34M | -15.38M | -29.88M | -62.58M | -68.57M | -22.05M | Investing Cash Flow |
-26.79M | -20.18M | 16.81M | 15.14M | -212.75M | 6.67M | Financing Cash Flow |
3.92M | 4.64M | 1.07M | 280.97M | 307.77M | 35.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $1.88B | 30.85 | 9.29% | 0.84% | 2.67% | -18.41% | |
69 Neutral | $1.39B | 20.86 | 11.04% | 1.59% | 1.35% | -40.63% | |
68 Neutral | $1.12B | 30.04 | 4.27% | 1.10% | -5.39% | 12.14% | |
66 Neutral | $4.49B | 12.22 | 5.40% | 3.71% | 4.17% | -11.97% | |
53 Neutral | $932.84M | ― | -1.15% | ― | 3.05% | 84.62% | |
50 Neutral | $1.45B | ― | -18.22% | 4.38% | 0.31% | -423.59% | |
47 Neutral | $1.56B | ― | -15.50% | ― | 19.35% | 27.83% |
On June 9, 2025, Xometry announced a proposed $225 million offering of Convertible Senior Notes due 2030 in a private placement. The proceeds from this offering are expected to be used for capped call transactions, repurchasing shares of Xometry’s Class A common stock, and repurchasing a portion of its outstanding 2027 notes. This strategic move aims to manage potential dilution, optimize capital structure, and potentially enhance market positioning, though it carries inherent market risks and uncertainties.
The most recent analyst rating on (XMTR) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Xometry stock, see the XMTR Stock Forecast page.
On May 27, 2025, Xometry, Inc. announced that its Chief Operating Officer, Peter Goguen, will be leaving the company effective June 30, 2025. In accordance with his employment agreement, Mr. Goguen will receive payments and benefits upon his departure, contingent upon his compliance with certain conditions including a general release and waiver of claims.
The most recent analyst rating on (XMTR) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Xometry stock, see the XMTR Stock Forecast page.